Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT05910801 · RECRUITING
Trial details
- NCT number
- NCT05910801
- Sponsor
- Academic and Community Cancer Research United
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2029-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.